COVID-19 continues to surge across the U.S. By Tuesday afternoon, Johns Hopkins University reported more than 7.82 million confirmed cases and the number of deaths approaching 215,480 by mid-afternoon Tuesday.

More than 30 states including Colorado, New York, Ohio and Wisconsin report a spike in confirmed cases over the past 14 days, based on Johns Hopkins data.

At least 10 U.S. states also set COVID-19 hospitalization records since last Friday, according to the COVID Tracking Project. 

About 35,056 patients were hospitalized in the U.S. on Monday, more than 16% higher than a week ago.

More children are also testing positive in the U.S. The American Academy of Pediatrics reports a 13% increase in child cases from September 24 to October 8, with more than 77,000 new infections.

That is consistent with the latest statistics from New York City. The number of COVID-19 cases among New York City public school staff and students has gone up 67% in the last week, the city’s Department of Education said Monday.

Since schools reopened on Sept. 8, a total of 305 people, 207 teachers and staff and 98 students, tested positive for the virus, according to the department.

New Jersey-based multinational corporation, Johnson & Johnson, announced on Monday that it had temporarily paused clinical trials for its candidate COVID-19 vaccine due to an unexplained illness in a study participant.

During the company's third quarter earnings call on Tuesday, Mathai Mammen, global head of research said, “It’s not at all unusual for unexpected illnesses to occur in large studies over their duration.” The illness, he added, may have nothing to do with the experimental vaccine.